A Conversation with Contraceptive R&D Leaders

 

In this discussion for the CTI Exchange's Beginning with the End in Mind series, Laneta Dorflinger, Director for Product Development and Introduction at FHI 360 sat down with Mark Barone, Deputy Director for Expand Method Choice at the Gates Foundation for a conversation about the future of contraceptive R&D and how we can design and develop new contraceptive methods that they will be acceptable, accessible, and affordable to the populations we are trying to serve.